INTERNATIONAL PATENT: ANLONG BIOPHARMACEUTICAL CO., LTD., 北京安龙生物医药有限公司 FILES APPLICATION FOR "OLIGONUCLEOTIDE TARGETING MTARC1 GENE AND USE THEREOF"

GENEVA, May 10 -- ANLONG BIOPHARMACEUTICAL CO., LTD. (Room 158, Floor 1, Building 1, Yard 10, Anxiang StreetShunyi District, Beijing 101318), 北京安龙生物医药有限公司 (中国北京市顺义区安祥街10号院1号楼1层158) filed a patent application (PCT/CN2025/131022) for "OLIGONUCLEOTIDE TARGETING MTARC1 GENE AND USE THEREOF" on Oct 29, 2025. With publication no. WO/2026/092544, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Worl...